Use of inhibitors of Brutons tyrosine kinase (Btk) Grant US-11672803-B2 United States of America 13 Jun 2023
Combination therapy using T cell redirection antigen binding molecule against cell having… Grant US-11660340-B2 United States of America 30 May 2023
Method for enhancing humoral immune response Grant US-11649293-B2 United States of America 16 May 2023
T cell-redirected antigen-binding molecule for cells having immunosuppression function Grant US-11505605-B2 United States of America 22 Nov 2022
Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK) Grant US-10954567-B2 United States of America 23 Mar 2021
Use of inhibitors of Bruton's tyrosine kinase (Btk) Grant US-10751342-B2 United States of America 25 Aug 2020
Use of inhibitors of bruton's tyrosine kinase (BTK) Grant US-10653696-B2 United States of America 19 May 2020
Use of inhibitors of bruton's tyrosine kinase (Btk) Grant US-10478439-B2 United States of America 19 Nov 2019
Use of inhibitors of Bruton's tyrosine kinase (Btk) Grant US-10016435-B2 United States of America 10 Jul 2018
Use of inhibitors of Bruton'S tyrosine kinase (Btk) Grant US-10004745-B2 United States of America 26 Jun 2018
Use of inhibitors of Bruton's tyrosine kinase (Btk) Grant US-10004746-B2 United States of America 26 Jun 2018
Phospholipase C gamma 2 and resistance associated mutations Grant US-9885086-B2 United States of America 06 Feb 2018
Use of inhibitors of bruton'S tyrosine kinase (BTK) Grant US-9814721-B2 United States of America 14 Nov 2017
T CELL-REDIRECTED ANTIGEN-BINDING MOLECULE FOR CELLS HAVING IMMUNOSUPPRESSION FUNCTION Application KR-20170017916-A Republic of Korea 15 Feb 2017